NEW YORK, January 10, 2014 /PRNewswire/ --

Today, Analysts' Corner announced new research reports highlighting HCP, Inc. (NYSE: HCP), Health Care REIT, Inc. (NYSE: HCN), DaVita HealthCare Partners Inc. (NYSE: DVA), IDEXX Laboratories, Inc. (NASDAQ: IDXX), and Thoratec Corp. (NASDAQ: THOR). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

HCP, Inc. Research Report

On January 7, 2014, HCP, Inc.'s (HCP) stock increased 1.71%, ending the day at $37.44. Over the previous three trading sessions, shares of HCP rose 3.40%, compared to the Dow Jones Industrial Average, which gained 0.54% during the same period. The Full Research Report on HCP, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.AnalystsCorner.com/r/full_research_report/6c26_HCP

--

Health Care REIT, Inc. Research Report

On January 7, 2014, Health Care REIT, Inc.'s (Health Care REIT) stock declined 0.06%, ending the day at $54.26. Over the previous three trading sessions, shares of Health Care REIT increased 1.34%, compared to the Dow Jones Industrial Average which gained 0.54% during the same period. The Full Research Report on Health Care REIT, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.AnalystsCorner.com/r/full_research_report/cf1e_HCN

--

DaVita HealthCare Partners Inc. Research Report

On January 7, 2014, DaVita HealthCare Partners Inc.'s (DaVita) stock rose 0.62%, ending the day at $65.20. Over the previous three trading sessions, shares of DaVita increased 0.65%, compared to the Dow Jones Industrial Average went up by 0.54% during the same period. The Full Research Report on DaVita HealthCare Partners Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.AnalystsCorner.com/r/full_research_report/5986_DVA

--

IDEXX Laboratories, Inc. Research Report

On January 6, 2014, IDEXX Laboratories, Inc. (IDEXX) announced that it will take part in the 32nd Annual J.P. Morgan Healthcare Conference. The Company added that its Chairman and CEO, Jonathan Ayers, will give a presentation on IDEXX on Monday, January 13, 2014 at 3:30 p.m. PST, at the Westin St. Francis Hotel, San Francisco, California. IDEXX stated that a live audio webcast of the presentation can be accessed via its website, where an archived edition of the presentation will also be available for 14 days. The Full Research Report on IDEXX Laboratories, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.AnalystsCorner.com/r/full_research_report/bf62_IDXX

--

Thoratec Corp. Research Report

On December 19, 2013, Thoratec Corp. (Thoratec) announced its participation in the 32nd Annual JP Morgan Healthcare Conference on January 13, 2014. The Company stated that its President and CEO, Gary F. Burbach, will give an update on the Company, starting at 8:00 a.m. PST/ 11:00 a.m. EST. Thoratec added that the presentation and subsequent breakout session can be accessed through the Company website. The Full Research Report on Thoratec Corp. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.AnalystsCorner.com/r/full_research_report/1bee_THOR

----

EDITOR NOTES: 


        
        1) This is not company news. We are an independent source and our views do
          not reflect the companies mentioned.
        2) Information in this release is fact checked and produced on a best efforts
          basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human
          and are prone to make mistakes. If you notice any errors or omissions, please notify
          us below.
        3) This information is submitted as a net-positive to companies mentioned, to
          increase awareness for mentioned companies to our subscriber base and the investing
          public.



        
        1) If you wish to have your company covered in more detail by our team, or
          wish to learn more about our services, please contact us at
          pubco@EquityNewsNetwork.com.
        2) For any urgent concerns or inquiries, please contact us at
          compliance@EquityNewsNetwork.com.
        3) Are you a public company? Would you like to see similar coverage on your
          company? Send us a full investors' package to research@EquityNewsNetwork.com for
          consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA(R) and Chartered Financial Analyst(R) are registered trademarks owned by CFA Institute.

SOURCE Analysts' Corner